Biotech

All Articles

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of considerable leadership hirings, shootings as...

Lykos are going to inquire FDA to reevaluate its own choice following turndown of MDMA therapy for post-traumatic stress disorder

.Observing a poor presenting for Lykos Rehabs' MDMA applicant for post-traumatic stress disorder at ...

AN 2 halves roll call, ceases period 3 test after data let down

.AN2 Therapeutics is actually reconsidering its own business in reaction to lackluster midphase data...

Merck spends $700M for bispecific, spying autoimmune opening as well as opportunity to challenge Amgen in cancer

.Merck &amp Co. is paying for $700 million ahead of time to challenge Amgen in a blood stream cancer...

Gilead pays out J&ampJ $320M to leave licensing bargain for seladelpar

.Along With Gilead Sciences almost an FDA decision for its liver condition medicine seladelpar, the ...

' All palms on deck' at Lilly as peers target being overweight market

.CEO David Ricks can easily view the business establishing tents at basecamp behind Eli Lilly in an ...

Entero laying off team, leaving office and stopping briefly R&ampD

.Mattress Liquidators has transformed Entero Therapies white as a piece. The creditor bought Entero ...

Exelixis loses ADC after choosing it is actually no match for Tivdak

.Exelixis is actually losing hope on its cells element (TF)- targeting antibody-drug conjugate after...

Relay dislikes SHP2 prevention after Genentech leaves

.Three full weeks after Roche's Genentech system ignored an SHP2 prevention deal, Relay Therapy has ...

Stoke's Dravet syndrome med launched of partial professional grip

.Stoke Rehabs' Dravet disorder medication has actually been actually without a partial hold, removin...